Brera Holdings PLC, a multi-club ownership group, is focusing on scaling operations and revenue streams with its recent acquisition of S.S. Juve Stabia S.r.l. The company aims to develop a global portfolio of emerging sports clubs, expanding its social impact football business. Meanwhile, Nuvectis Pharma, a biotech company, is gaining attention from investors with sustained insider buying and promising oncology candidates, signaling potential growth in the second half of 2025.